SPY453.42-3.98 -0.87%
DIA346.24-0.37 -0.11%
IXIC15,085.47-295.85 -1.92%

NRX Pharmaceuticals to Start High Volume Production of Zyesami COVID Treatment For Trials After Getting US FDA Approval

MT Newswires · 11/11/2021 04:52

Please log in to view news